5:50 PM
 | 
Apr 21, 2010
 |  BC Extra  |  Financial News

Genzyme reports earnings

Genzyme Corp. (NASDAQ:GENZ) reported 1Q10 non-GAAP diluted EPS of $0.37, beating by $0.04 the Street's estimate of $0.33 and down from $0.82 in 1Q09. The EPS figure excludes stock compensation expenses,...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >